Adagen Articles
Italy’s Sigma-Tau to takeover Enzon business for some $327 million in cash plus royalties
10 November 2009
Enzon swings to $286M loss in 4th-qtr 2005
13 March 2006
Enzon - improving the delivery and side effect profile of proven
20 January 1999
Cortex, Enzon And Mylan Results
11 September 1997
ENZON'S ONCASPAR APPROVED IN USA
14 February 1994
Showing 1-7 of 7 articles
- 1
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
